Breast cancer risk scores change over time, with those who go on to develop cancer showing unique patterns that could provide valuable guidance into their diagnostic needs.
The manufacturer issued an alert in January, indicating its Brevera Breast Biopsy System Disposable 9 Gauge Needles were being recalled amid risk they might leave metallic particles in tissue.
When CMS shared a list of cardiologists being targeted with a brand new payment model, the American College of Cardiology identified a long list of apparent mistakes.
Plaintiff attorneys believe this is the largest non-death-related malpractice payout in the history of Maine, with Brewer-based Northern Light Health system on the hook for the damages.
The two said they’ve been negotiating terms for eight months. Sticking points include denied claims and coverage disputes, with both the insurer and health system pointing fingers.
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.
"Today’s sentence sends a deterrent message to doctors and the healthcare industry," according to a DOJ statement. "If you abuse patient trust for profit, you will face justice."
Breast cancer risk scores change over time, with those who go on to develop cancer showing unique patterns that could provide valuable guidance into their diagnostic needs.
